R. Dummer

Therapy of Cutaneous Lymphoma – Current Practice and Future Developments

R. Dummer, G. Burg, W. Kempf, 2003, Oncology Research and Treatment.

Blastic natural killer‐cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?

R. Dummer, G. Burg, T. Mentzel, 2003, The British journal of dermatology.

Primary cutaneous lymphoma: two‐decade comparison in a population of 263 cases from a Swiss tertiary referral centre

A. Cozzio, P. Golling, L. E. French, 2011, The British journal of dermatology.

Imiquimod in basal cell carcinoma: how does it work?

R. Dummer, K. Hoek, G. Burg, 2003, The British journal of dermatology.

Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA

H. Joller-jemelka, R. Dummer, G. Burg, 1996, Archives of Dermatological Research.

Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy.

J. Becker, R. Dummer, G. Burg, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity.

J. Becker, R. Dummer, G. Burg, 1991, Journal of immunology.